A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder

The efficacy, safety, and tolerability of Lu AA21004 vs. placebo using venlafaxine XR as active reference in patients with DSM-IV-TR major depressive disorder (MDD) were evaluated. Lu AA21004 is a novel antidepressant that is a 5-HT(3) and 5-HT(7) receptor antagonist, 5-HT(1A) receptor agonist, 5-HT...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez, Enric, Perez, Victor, Dragheim, Marianne, Loft, Henrik, Artigas, Francesc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349292/
https://www.ncbi.nlm.nih.gov/pubmed/21767441
http://dx.doi.org/10.1017/S1461145711001027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349292/
https://www.ncbi.nlm.nih.gov/pubmed/21767441
http://dx.doi.org/10.1017/S1461145711001027

Ejemplares similares